Scientists are reporting development of a potential new way of enabling patients with bacterial keratitis to stick with the extraordinarily intensive treatment needed for this potentially blinding eye infection. The disease affects more than 500,000 people each year worldwide, including 30,000 people in the United States. The study is in ACS' Molecular Pharmaceutics, a bi-monthly journal. Howida Kamal Ibrahim and colleagues explain that bacterial keratitis is a rapidly-progressing infection of the cornea, the clear tissue covering the front of the eye...
More...
More...